CODX

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. It also uses its technology to design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. It also sells diagnostic equipment from other manufacturers as self-contained lab systems. The Company is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.